View in EDS

Thirty-Day Readmissions and Predictors of Adverse Outcomes After Bronchoscopic Lung Volume Reduction in the United States, 2019-2022.

Saved in:

Bibliographic Details
Title:	Thirty-Day Readmissions and Predictors of Adverse Outcomes After Bronchoscopic Lung Volume Reduction in the United States, 2019-2022.
Authors:	Patel M; Department of Internal Medicine, UTHealth Houston, Houston, TX, United States., Vijayan K; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Florida, Gainesville, FL, United States., Khamooshi P; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Florida, Gainesville, FL, United States., Burgei J; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Florida, Gainesville, FL, United States., Patel P; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Florida, Jacksonville, FL, United States., Mehta HJ; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Florida, Gainesville, FL, United States.
Source:	Annals of the American Thoracic Society [Ann Am Thorac Soc] 2026 Jun 24. Date of Electronic Publication: 2026 Jun 24.
Publication Type:	Journal Article
Journal Info:	Publisher: American Thoracic Society Country of Publication: England NLM ID: 101600811 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2325-6621 (Electronic) Linking ISSN: 23256621 NLM ISO Abbreviation: Ann Am Thorac Soc Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2325-6621
DOI:	10.1093/annalsats/aaoag164